We are live on ! Find out more
FC

FORA Capital Portfolio holdings

AUM $1.36B
1-Year Est. Return 56.1%
This Fund
S&P 500
This Quarter Est. Return
+17.03%
1 Year Est. Return
+56.1%
3 Year Est. Return
+119.91%
5 Year Est. Return
+163.37%
10 Year Est. Return
AUM
$153M
AUM Growth
-$140M
Cap. Flow
-$156M
Cap. Flow %
-102.53%
Top 10 Hldgs %
23.99%
Holding
1,132
New
281
Increased
115
Reduced
205
Closed
513

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.3M
2
BABA icon
Alibaba
BABA
+$5.2M
3
HYLN icon
Hyliion Holdings
HYLN
+$4.06M
4
LULU icon
lululemon athletica
LULU
+$3.31M
5
JD icon
JD.com
JD
+$3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.17%
2 Communication Services 16.69%
3 Healthcare 12.57%
4 Technology 11.76%
5 Consumer Staples 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAG
451
DELISTED
AMAG Pharmaceuticals
AMAG
$46K 0.03%
4,887
CRH icon
452
CRH
CRH
$69.1B
$45K 0.03%
+1,243
New +$46.8K
ITT icon
453
ITT
ITT
$17.8B
$45K 0.03%
+768
New +$46.5K
MIDD icon
454
Middleby
MIDD
$6.11B
$45K 0.03%
+503
New +$45.6K
SNN icon
455
Smith & Nephew
SNN
$13.7B
$45K 0.03%
1,140
-478
-30% -$19.2K
OTEX icon
456
Open Text
OTEX
$6.02B
$44K 0.03%
+1,034
New +$45.2K
TVTX icon
457
Travere Therapeutics
TVTX
$5.2B
$44K 0.03%
2,387
-5,679
-70% -$110K
MTOR
458
DELISTED
MERITOR, Inc.
MTOR
$44K 0.03%
+2,124
New +$47.8K
MNR
459
DELISTED
Monmouth Real Estate Investment Corp
MNR
$44K 0.03%
3,182
CRSP icon
460
CRISPR Therapeutics
CRSP
$4.68B
$43K 0.03%
517
-10,198
-95% -$905K
CYRX icon
461
CryoPort
CYRX
$765M
$43K 0.03%
901
-5,952
-87% -$241K
DD icon
462
DuPont de Nemours
DD
$19B
$43K 0.03%
+613
New +$43K
INSM icon
463
Insmed
INSM
$22.6B
$43K 0.03%
1,336
-2,992
-69% -$86K
OC icon
464
Owens Corning
OC
$11.5B
$43K 0.03%
+628
New +$40.3K
VRNT
465
DELISTED
Verint Systems
VRNT
$43K 0.03%
+1,737
New +$40.5K
FLGT icon
466
Fulgent Genetics
FLGT
$558M
$42K 0.03%
+1,049
New +$32.8K
GGG icon
467
Graco
GGG
$13.3B
$42K 0.03%
+679
New +$37.9K
VSAT icon
468
Viasat
VSAT
$10.2B
$42K 0.03%
+1,227
New +$46.4K
CYTK icon
469
Cytokinetics
CYTK
$10.8B
$41K 0.03%
+1,907
New +$44.6K
DTIL icon
470
Precision BioSciences
DTIL
$185M
$41K 0.03%
219
LPG icon
471
Dorian LPG
LPG
$1.9B
$41K 0.03%
5,060
MNRO icon
472
Monro
MNRO
$537M
$41K 0.03%
+1,014
New +$51.7K
TTGT icon
473
TechTarget
TTGT
$323M
$41K 0.03%
930
-1,966
-68% -$74.1K
UGI icon
474
UGI
UGI
$7.92B
$41K 0.03%
1,252
-504
-29% -$16.7K
AN icon
475
AutoNation
AN
$7.37B
$40K 0.03%
749
+305
+69% +$15.9K

Similar funds

FORA Capital's Q3 2020 Portfolio in Review

As of Q3 2020, FORA Capital held 1,132 positions worth $153M, down 48% from $292M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

FORA Capital withdrew a net $156M in Q3 2020, closing 513 positions and reducing 205 holdings. Its most notable exit was Alibaba, an estimated $5.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, FORA Capital opened a new position in Procter & Gamble worth $3.32M.

  • FORA Capital's largest Q3 2020 buy was Procter & Gamble: 23,884 shares worth $3.32M.
  • FORA Capital added most to Meta Platforms (Facebook) in Q3 2020, an estimated $9.25M increase.
  • FORA Capital's biggest Q3 2020 reduction was Apple, cutting an estimated $13.3M.
  • FORA Capital fully exited Alibaba in Q3 2020, selling an estimated $5.2M.
  • FORA Capital's ten largest holdings make up 24% of its $153M portfolio in Q3 2020.
  • FORA Capital opened 281 new positions and closed 513 in Q3 2020.
  • FORA Capital's portfolio value fell 48% quarter-over-quarter to $153M.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.